Janus Henderson Investors — 2023 Investments

2 investments dated 2023 · listed companies and verified rows first · show all

CARGO Therapeuticscargo-tx.com inFeb 2023

Launched by Samsara in partnership with CAR T pioneers, advancing a clinically validated CD22 CAR T for lymphoma.

BiotechSan Mateo, US

Gina Chapman(Executive Officer, Director)inAnup Radhakrishnan(Executive Officer)inCassandra Gianna Luca(Director)Jeffrey Walsh(Director)Krishnan Viswanadhan(Director)

BoardAbraham Bassan(Director)

Co-investorsNextech Invest Red Tree Venture Samsara BioCapital Wellington Management Ally Bridge Group Perceptive Xontogeny Venture +1 more

Morphimmunemorphimmune.com inJun 2023

HealthtechWest Lafayette, US

Philip Low, Ph.D.(Director)Sunil Singhal, M.D.(Director)Isaac Barchas(Director)Clay B. Siegall, Ph.D.(Executive Officer, Director)Ronald Martell(Director)inFranklyn Prendergast, M.D., Ph.D.(Director)

Co-investorsEcoR1 Capital Arsenal Bridge Venture REDMILE

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.